RecruitingNCT06237790

Auditory Restoration and Outcomes After Gene Therapy and Cochlear Implantation: a PRospective Cohort Analysis (AURORA)

Sponsor

Eye & ENT Hospital of Fudan University

Enrollment

180 participants

Start Date

Apr 6, 2024

Study Type

OBSERVATIONAL

Conditions

Genetic Disease Hearing Loss Speech Perception

Summary

This cohort study aims to explore the trends and differences in multidimensional perceptual levels of patients after cochlear implants or gene therapy, as well as to comprehensively assess the efficacy of gene therapy for congenital deafness, thus providing a reference for making a well-rounded postoperative rehabilitation protocol for gene therapy patients.

Eligibility

Min Age: 6 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with genetic disease, hearing loss, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 6 Months and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.